10-Q Filing

LifeMD, Inc. CIK: 948320 Q2 2015

Filing Information

Form Type	10-Q
Accession Number	`0001213900-15-006051`
Period End Date	20150630
Filing Date	20150813
Fiscal Year	2015
Fiscal Period	Q2
XBRL Instance	immd-20150630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 42 Income Statement 60 Cash Flow Statement 46 Stockholders Equity 13

Balance Sheet 42 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	30.61M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	30.61M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$75.50K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$79.55K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$61.15K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$155.06K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	30.61M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	30.61M	shares	Point-in-time
Trade accounts receivable	`AccountsReceivableNetCurrent`	$135.32K	USD	Point-in-time
Trade accounts receivable	`AccountsReceivableNetCurrent`	$14.97K	USD	Point-in-time
Inventory, net	`InventoryNet`	$41.01K	USD	Point-in-time
Inventory, net	`InventoryNet`	$21.48K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$236.35K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$131.47K	USD	Point-in-time
Furnishings and equipment, net	`PropertyPlantAndEquipmentNet`	$15.26K	USD	Point-in-time
Furnishings and equipment, net	`PropertyPlantAndEquipmentNet`	$43.75K	USD	Point-in-time
Total Assets	`Assets`	$251.61K	USD	Point-in-time
Total Assets	`Assets`	$175.22K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$274.32K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$314.19K	USD	Point-in-time
Notes payable	`NotesPayable`	$27.20K	USD	Point-in-time
Notes payable	`NotesPayable`	$98.49K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$412.67K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$301.52K	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$13.20K	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$4.60K	USD	Point-in-time
Total Liabilities	`Liabilities`	$314.72K	USD	Point-in-time
Total Liabilities	`Liabilities`	$417.27K	USD	Point-in-time
Common stock, $0.01 par value; 50,000,000 shares authorized, 30,609,973 shares issued and outstanding at June 30, 2015	`CommonStockValue`	$306.10K	USD	Point-in-time
Common stock, $0.01 par value; 50,000,000 shares authorized, 30,609,973 shares issued and outstanding at June 30, 2015	`CommonStockValue`	$307.30K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$8.08M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$8.07M	USD	Point-in-time
Accumulated (deficit)	`RetainedEarningsAccumulatedDeficit`	$-8.52M	USD	Point-in-time
Accumulated (deficit)	`RetainedEarningsAccumulatedDeficit`	$-8.54M	USD	Point-in-time
Total Stockholders' (Deficit)	`StockholdersEquity`	$-165.66K	USD	Point-in-time
Total Stockholders' (Deficit)	`StockholdersEquity`	$-139.50K	USD	Point-in-time
Total Liabilities and Stockholders' (Deficit)	`LiabilitiesAndStockholdersEquity`	$175.22K	USD	Point-in-time
Total Liabilities and Stockholders' (Deficit)	`LiabilitiesAndStockholdersEquity`	$251.61K	USD	Point-in-time

Income Statement 60 line items

Line Item	Tag	Value	Unit	Period
Sales	`Revenues`	$196.61K	USD	1 Quarter
Sales	`Revenues`	$277.35K	USD	1 Quarter
Sales	`Revenues`	$389.04K	USD	2 Qtrs
Sales	`Revenues`	$565.63K	USD	2 Qtrs
Cost of sales	`CostOfRevenue`	$89.50K	USD	1 Quarter
Cost of sales	`CostOfRevenue`	$118.25K	USD	2 Qtrs
Cost of sales	`CostOfRevenue`	$163.72K	USD	2 Qtrs
Cost of sales	`CostOfRevenue`	$69.16K	USD	1 Quarter
Gross Profit	`GrossProfit`	$127.45K	USD	1 Quarter
Gross Profit	`GrossProfit`	$187.85K	USD	1 Quarter
Gross Profit	`GrossProfit`	$270.79K	USD	2 Qtrs
Gross Profit	`GrossProfit`	$401.91K	USD	2 Qtrs
Compensation and related expenses	`CompensationAndRelatedExpenses`	$200.16K	USD	2 Qtrs
Compensation and related expenses	`CompensationAndRelatedExpenses`	$114.03K	USD	1 Quarter
Compensation and related expenses	`CompensationAndRelatedExpenses`	$114.77K	USD	1 Quarter
Compensation and related expenses	`CompensationAndRelatedExpenses`	$278.06K	USD	2 Qtrs
Professional fees	`ProfessionalFees`	$26.00K	USD	1 Quarter
Professional fees	`ProfessionalFees`	$61.82K	USD	2 Qtrs
Professional fees	`ProfessionalFees`	$80.60K	USD	2 Qtrs
Professional fees	`ProfessionalFees`	$26.31K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$149.26K	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$62.79K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$165.16K	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$63.93K	USD	1 Quarter
Operating (Loss)	`OperatingIncomeLoss`	$-9.34K	USD	2 Qtrs
Operating (Loss)	`OperatingIncomeLoss`	$-253.01K	USD	2 Qtrs
Operating (Loss)	`OperatingIncomeLoss`	$-75.38K	USD	1 Quarter
Operating (Loss)	`OperatingIncomeLoss`	$-17.17K	USD	1 Quarter
License Fee	`LicenseCosts`	-	USD	2 Qtrs
License Fee	`LicenseCosts`	$-25.00K	USD	2 Qtrs
License Fee	`LicenseCosts`	-	USD	1 Quarter
License Fee	`LicenseCosts`	-	USD	1 Quarter
Other income	`OtherIncome`	-	USD	1 Quarter
Other income	`OtherIncome`	$7.88K	USD	2 Qtrs
Other income	`OtherIncome`	-	USD	1 Quarter
Other income	`OtherIncome`	-	USD	2 Qtrs
Interest (expense)	`InterestExpense`	$8.16K	USD	1 Quarter
Interest (expense)	`InterestExpense`	$906.00	USD	2 Qtrs
Interest (expense)	`InterestExpense`	$428.00	USD	1 Quarter
Interest (expense)	`InterestExpense`	$18.63K	USD	2 Qtrs
Net (Loss) Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-25.33K	USD	1 Quarter
Net (Loss) Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-75.81K	USD	1 Quarter
Net (Loss) Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-221.04K	USD	2 Qtrs
Net (Loss) Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-27.96K	USD	2 Qtrs
Deferred income tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-8.60K	USD	2 Qtrs
Deferred income tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-4.30K	USD	1 Quarter
Deferred income tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-4.30K	USD	1 Quarter
Deferred income tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-8.60K	USD	2 Qtrs
Net (Loss)	`NetIncomeLoss`	$-19.36K	USD	2 Qtrs
Net (Loss)	`NetIncomeLoss`	$-71.50K	USD	1 Quarter
Net (Loss)	`NetIncomeLoss`	$-212.44K	USD	2 Qtrs
Net (Loss)	`NetIncomeLoss`	$-21.03K	USD	1 Quarter
Basic and diluted (loss) per share	`WeightedAverageNumberOfSharesOutstandingBasic`	0.00	shares	2 Qtrs
Basic and diluted (loss) per share	`WeightedAverageNumberOfSharesOutstandingBasic`	0.00	shares	1 Quarter
Basic and diluted (loss) per share	`WeightedAverageNumberOfSharesOutstandingBasic`	0.00	shares	1 Quarter
Basic and diluted (loss) per share	`WeightedAverageNumberOfSharesOutstandingBasic`	-0.01	shares	2 Qtrs
Average number of common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	30.19M	shares	2 Qtrs
Average number of common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	30.20M	shares	1 Quarter
Average number of common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	30.69M	shares	2 Qtrs
Average number of common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	30.65M	shares	1 Quarter

Cash Flow Statement 46 line items

Line Item	Tag	Value	Unit	Period
Net (Loss)	`NetIncomeLoss`	$-19.36K	USD	2 Qtrs
Net (Loss)	`NetIncomeLoss`	$-71.50K	USD	1 Quarter
Net (Loss)	`NetIncomeLoss`	$-212.44K	USD	2 Qtrs
Net (Loss)	`NetIncomeLoss`	$-21.03K	USD	1 Quarter
Depreciation	`Depreciation`	$28.49K	USD	2 Qtrs
Depreciation	`Depreciation`	$28.49K	USD	2 Qtrs
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-8.60K	USD	2 Qtrs
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-4.30K	USD	1 Quarter
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-4.30K	USD	1 Quarter
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-8.60K	USD	2 Qtrs
Stock compensation expense	`ShareBasedCompensation`	$3.50K	USD	2 Qtrs
Stock compensation expense	`ShareBasedCompensation`	$4.00K	USD	2 Qtrs
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	-	USD	2 Qtrs
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$28.00K	USD	2 Qtrs
Trade accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$120.36K	USD	2 Qtrs
Trade accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$7.79K	USD	2 Qtrs
Legal settlement proceeds receivable	`IncreaseDecreaseInLegalSettlement`	-	USD	2 Qtrs
Legal settlement proceeds receivable	`IncreaseDecreaseInLegalSettlement`	$-132.00K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$-2.68K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$-19.53K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$57.26K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$39.87K	USD	2 Qtrs
Net cash (used) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-56.43K	USD	2 Qtrs
Net cash (used) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$23.09K	USD	2 Qtrs
Investment in Adiuvo Investment S. A.	`PaymentsToAcquireInterestInJointVenture`	$100.00K	USD	2 Qtrs
Investment in Adiuvo Investment S. A.	`PaymentsToAcquireInterestInJointVenture`	-	USD	2 Qtrs
Increase in notes payable	`IncreaseDecreaseInNotesPayableCurrent`	$130.00K	USD	2 Qtrs
Increase in notes payable	`IncreaseDecreaseInNotesPayableCurrent`	-	USD	2 Qtrs
Repayment of notes payable	`RepaymentsOfNotesPayable`	$17.00K	USD	2 Qtrs
Repayment of notes payable	`RepaymentsOfNotesPayable`	$58.71K	USD	2 Qtrs
Purchase of Company stock	`PaymentsOfDividendsCommonStock`	$10.80K	USD	2 Qtrs
Purchase of Company stock	`PaymentsOfDividendsCommonStock`	-	USD	2 Qtrs
Net cash provided (used) by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$60.49K	USD	2 Qtrs
Net cash provided (used) by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-17.00K	USD	2 Qtrs
Net increase (decrease) in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$4.05K	USD	2 Qtrs
Net increase (decrease) in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-93.91K	USD	2 Qtrs
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$75.50K	USD	Point-in-time
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$79.55K	USD	Point-in-time
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$61.15K	USD	Point-in-time
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$155.06K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$75.50K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$79.55K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$61.15K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$155.06K	USD	Point-in-time
Cash paid during the period for interest	`InterestPaid`	$18.63K	USD	2 Qtrs
Cash paid during the period for interest	`InterestPaid`	-	USD	2 Qtrs

Stockholders Equity 13 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$-165.66K	USD	Point-in-time
Balance	`StockholdersEquity`	$-139.50K	USD	Point-in-time
Stock compensation expense	`ShareBasedCompensation`	$3.50K	USD	2 Qtrs
Stock compensation expense	`ShareBasedCompensation`	$4.00K	USD	2 Qtrs
Purchase of Company stock	`StockIssuedDuringPeriodValueNewIssues`	$10.80K	USD	Point-in-time
Purchase of Company stock	`StockIssuedDuringPeriodValueNewIssues`	$-10.80K	USD	2 Qtrs
Purchase of Company stock, shares	`StockIssuedDuringPeriodSharesNewIssues`	120,000.00	shares	Point-in-time
Net (loss)	`NetIncomeLoss`	$-19.36K	USD	2 Qtrs
Net (loss)	`NetIncomeLoss`	$-71.50K	USD	1 Quarter
Net (loss)	`NetIncomeLoss`	$-212.44K	USD	2 Qtrs
Net (loss)	`NetIncomeLoss`	$-21.03K	USD	1 Quarter
Balance	`StockholdersEquity`	$-165.66K	USD	Point-in-time
Balance	`StockholdersEquity`	$-139.50K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.